Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer

Chrishani Rodrigo, Kamani Hemamala Tennekoon, Eric Hamilton Karunanayake, Kanishka De Silva, Indrani Amarasinghe, Ananda Wijayasiri
2017 Endocrine journal  
BREAST CANCER is the commonest cancer and second leading cause of cancer death in women worldwide [1] . Currently it is the commonest cancer in Sri Lankan women with a cumulative incidence rate of 2.558 % and age standardised incidence rate (ASR) of 23 per 100,000 women [2] . Multiple factors including genetic, hormonal and environmental factors are associated with breast cancer. Obesity is a well-known risk factor for breast cancer [3] . In obesity adipokine secretion by the subcu-Circulating
more » ... subcu-Circulating leptin, soluble leptin receptor, free leptin index, visfatin and selected leptin and leptin receptor gene polymorphisms in sporadic breast cancer Abstract. Leptin and visfatin are implicated in breast cancer risk but studies accounting for bioavailability of leptin are sparse. Reports on the association of leptin gene (LEP) and leptin receptor gene (LEPR) polymorphisms with breast cancer are also inconsistent. Only a very few studies have examined biochemical and genetic variables concomitantly in the same cohort. A matched pairs study was carried out to ascertain whether plasma leptin, soluble leptin receptor, free leptin index (leptin/soluble leptin receptor), serum visfatin and selected LEP and LEPR polymorphisms are risk factors for sporadic breast cancer. Newly diagnosed sporadic breast cancer patients (N=80) were matched for age, body mass index (BMI) and menopausal status with healthy controls. Plasma leptin, soluble leptin receptor and serum visfatin were measured by enzyme-immunoassay. LEP -2548 A/G and LEPR K109R, LEPR Q223R polymorphisms were determined by genotyping. Leptin (p=0.0234), leptin/BMI (p=0.0468), free leptin index (p<0.0001) and visfatin (p=0.0002) were significantly higher and soluble leptin receptor (p<0.0001) was significantly lower in patients. LEPR gene K109R A/G polymorphism increased breast cancer risk (odds ratio: 4.125). Multivariate analysis confirmed that leptin, soluble leptin receptor, free leptin index and G109 (R109) allele of the LEPR gene K109R polymorphism are risk factors for breast cancer. When stratified by menopausal status free leptin index and soluble leptin receptor remained as risk factors irrespective of menopausal status while LEPR gene K109R A/G polymorphism remained as a risk factor only in the postmenopausal group.
doi:10.1507/endocrj.ej16-0448 pmid:28190851 fatcat:rpj4yffu6nha5ow7xbpjsff3ee